BioSpace News Archive

- Laborie Medical Technologies Inc. signed a definitive agreement today and entered into a multi-faceted, strategic partnership with Urotronic Inc. (Urotronic), a Minnesota-based medical device company currently conducting clinical trials to support regulatory approval of Optilume™,

Leon Medical Centers Health Plans, a Cigna company, announced it has achieved Five out of Five Stars for quality and performance from the Centers for Medicare & Medicaid Services for 2021.

The U.S. Food and Drug Administration’s mission to protect and promote public health by ensuring the safety of the nation’s food supply, as well as the safety and efficacy of medical products, has always relied on a rigorous analysi

Athersys, Inc. will release its third quarter 2020 financial results at approximately 4:00 PM Eastern Time on Monday, November 9, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its August 2020 SARS-CoV-2 Testing Survey for clinical laboratories.

eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today that the company plans to release third quarter 2020 financial results on October 22, 2020.

Patients who recovered from COVID-19 at St. Luke’s University Health Network have donated their antibody-rich blood to medical science in hopes of helping to find an effective treatment or cure to the novel coronavirus that has killed nearly 200,000 Americans.

NIAID has initiated a Phase 3 clinical trial to evaluate the safety, tolerability, and efficacy of hyperimmune globulin products, including Emergent’s COVID-19 Human Immune Globulin (COVID-HIG), as a potential treatment in adult patients hospitalized with COVID-19 Emergent is planning additional clinical trials to evaluate COVID-HIG for potential use in other patient populations or individuals at high risk of exposure GAITHERSBURG, Md., Oct. 08, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolution

In response to states of emergency declared in Alabama , Louisiana , and Mississippi in anticipation of Hurricane Delta, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for affected members.

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2021 on Thursday, October 29, 2020, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this call. Earnings webcast details: